Diagnostics
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Voice-of-Customer Research
Unbiased. Unfiltered. If you want to know what your current or potential customers think, and what motivates their behavior, then you’ve come to right place. No one gets more comprehensive and nuanced information from real-world life science stakeholders than we do. Period.
Selected Work

Before the precision medicine strategy, the precision medicine map.
Market Opportunity Landscaping
Stretch growth targets in a market that was commoditizing underneath.
Product Strategy / Portfolio Planning
Go-to-Market / Growth Strategy

Seven pharmas, two access strategies, one consortium-funded path forward.
Investment Diligence






.png)





